The Bill Kelly Show Podcast:
In Ontario, there are dozens of different ways to book a vaccine, depending on your age, health status and location. Unfortunately, many of them are frustrating, confusing and inefficient.
Nova Scotia has one centralized booking system through which residents can choose from a list of all available vaccine appointments in the province, including community health clinics, primary care practices and pharmacies.
CANImmunize, the company hired to build Nova Scotia’s vaccine booking and management system, is an Ontario-based company. But despite having worked with the provincial government here in the past on a globally recognized digital immunization tracking app, they were not asked to work on the COVID-19 platform.
The end-to-end system covers everything from appointment bookings to setting up clinics to autobooking second doses. CANImmunize has a similar contract with Yukon, and has been hired by P.E.I. to provide digital immunization records to its citizens.
GUEST: Katherine Atkinson, Chief Operating Officer of CANImmunize
-
Biolyse is a small pharmaceutical manufacturer in Canada with a simple proposition: provide a recipe for a coronavirus vaccine, and it will produce 20m doses for nations in the global south. It has approached AstraZeneca and Johnson & Johnson, and even asked the Canadian government to help it with compulsory licensing – which would give it the authorisation to produce another company’s patented product for emergency use – but so far no one has taken up its offer.
The situation is dire, and we need more vaccines. At the moment, there is no worldwide joined-up effort to expand production. As incredible as it sounds, after all the public money that went into vaccine development, making and distributing them has been left entirely up to the market. Each company has its own – totally secret – recipes and supply chains, and they insist no other approach is possible.
Many governments and organisations back the idea of opening up production. India and South Africa have asked the WTO to suspend patent protections to allow other companies to produce existing vaccines and drugs – but they have been blocked by rich nations
GUEST: Dr. Nancy Olivieri, Physician and a Professor of Pediatrics, Medicine and Public Health Sciences at the University of Toronto and a Senior Scientist at Toronto General Hospital
-
A new poll suggests Canadians are mostly giving a collective shrug to the latest federal budget, which has also barely affected the Liberals’ chances of winning the next election.
The Ipsos poll conducted exclusively for Global News found 62 per cent of Canadians who responded didn’t have a positive or negative opinion of the budget. An equal number of those surveyed — 19 per cent — gave the budget a thumbs up or a thumbs down.
GUEST: Darrel Bricker, CEO of Ipsos Public Affairs
See omnystudio.com/listener for privacy information.